Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 5:20 PM UTC
| NCT Number | NCT05886049 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 38 participants |
| Active Locations | 23 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 25, 2026 (Aug 25, 2026) |
As of October 12, 2026: Clinical trial NCT05886049 is currently recruiting participants. This phase1 study for acute myeloid leukemia is actively seeking new participants at 23 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05886049 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 23 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05886049 was last updated Aug 25, 2026 (August 25, 2026). HelloStudys verifies this status automatically.